Indigo Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Indigo Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3452
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Indigo Biosciences Inc (Indigo) is a provider of preclinical contract research services. The company’s products include assay kit platforms and formats, nuclear receptor, signaling pathway, and cell viability assay products, mitochondrial function products, and luciferase detection reagents. Its other products comprise assay and format plates, human liver receptors, human nucelar factro assay systems, human and rat pregnane X receptors, NFkB assay systems, and human estrogen related receptor gamma assay systems. Indigo offers services such as screening, contract research, nuclear receptor reporter assays and panel services, custom assay development services, and others. The company serves pharmaceutical research and development, biotechnology sectors. Indigo is headquartered in State College, Pennsylvania, the US.

Indigo Biosciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Indigo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Indigo Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Indigo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Indigo Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 8
Indigo Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Indigo Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Indigo Biosciences Raises USD0.5 Million in Series B Financing 10
Private Equity 11
iNetworks Invests In Indigo Biosciences 11
Partnerships 12
Indigo Biosciences Enters into Distribution Agreement with upcyte technologies 12
Indigo Biosciences Inc – Key Competitors 13
Indigo Biosciences Inc – Key Employees 14
Indigo Biosciences Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Indigo Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts 2
Indigo Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Indigo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Indigo Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Indigo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Indigo Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 8
Indigo Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Indigo Biosciences Raises USD0.5 Million in Series B Financing 10
iNetworks Invests In Indigo Biosciences 11
Indigo Biosciences Enters into Distribution Agreement with upcyte technologies 12
Indigo Biosciences Inc, Key Competitors 13
Indigo Biosciences Inc, Key Employees 14

List of Figures
Indigo Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Indigo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Indigo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Indigo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Indigo Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Indigo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Indigo Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[Indigo Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sunovion Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Sunovion Pharmaceuticals Inc (Sunovion), a subsidiary of Sumitomo Dainippon Pharma Co Ltd, is a research-based pharmaceutical company. It discovers, develops and commercializes therapeutic products that focus on the treatment of central nervous system and respiratory disorders. Its product p …
  • Alon USA Energy, Inc.:企業の戦略・SWOT・財務情報
    Alon USA Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary Alon USA Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Daqo New Energy Corp (DQ)-エネルギー分野:企業M&A・提携分析
    Summary Daqo New Energy Corp (Daqo Cayman) is a manufacturer of polysilicon and solar wafers. Through tolling agreements, the company also offers wafer original equipment manufacturer (OEM) services to external customers. It sells its products to solar cell and solar module manufacturers. Daqo Cayma …
  • Owen Mumford Ltd:企業の戦略的SWOT分析
    Owen Mumford Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Kohler Co.:企業の戦略・SWOT・財務分析
    Kohler Co. - Strategy, SWOT and Corporate Finance Report Summary Kohler Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Sanquin Blood Supply Foundation:製薬・医療:M&Aディール及び事業提携情報
    Summary Sanquin Blood Supply Foundation (Sanquin) is a provider of blood bank and diagnostic services, plasma derived products, tissues and cells and reagents. It offers blood-related lab tests for hospitals, blood banks, obstetricians practices, pharmaceutical companies, insurance organizations, an …
  • Denbury Resources Inc (DNR):企業の財務・戦略的SWOT分析
    Denbury Resources Inc (DNR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • PT Pembangkitan Jawa-Bali:企業の戦略的SWOT分析
    PT Pembangkitan Jawa-Bali - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Crown Resorts Ltd:企業の戦略・SWOT・財務情報
    Crown Resorts Ltd - Strategy, SWOT and Corporate Finance Report Summary Crown Resorts Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Pioneer Distilleries Limited:企業の戦略・SWOT・財務分析
    Pioneer Distilleries Limited - Strategy, SWOT and Corporate Finance Report Summary Pioneer Distilleries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Orica Limited:戦略・SWOT・企業財務分析
    Orica Limited - Strategy, SWOT and Corporate Finance Report Summary Orica Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Serina Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Serina Therapeutics Inc (Serina Therapeutics) is a drug company that develops therapeutics for cancer, inflammation, pain, and metabolic disorders. The company’s pipeline product includes SER-214, SER-226, SER-228, SER-232, and other proprietary drugs. It uses proprietary technology, polyoxa …
  • Sanofi-Aventis Korea Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Sanofi-Aventis Korea Co Ltd (Sanofi-Aventis), a subsidiary of Sanofi is a developer, manufacturer and distributor of generic drugs and medical equipment. The company’s products include note vials lantus, lantus state solo star, she feeds the main vial la, feed her a solo star la shares, elro …
  • Olvi plc:企業の戦略・SWOT・財務情報
    Olvi plc - Strategy, SWOT and Corporate Finance Report Summary Olvi plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Biman Bangladesh Airlines Ltd.:企業の戦略・SWOT・財務情報
    Biman Bangladesh Airlines Ltd. - Strategy, SWOT and Corporate Finance Report Summary Biman Bangladesh Airlines Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Fujifilm SonoSite Inc-医療機器分野:企業M&A・提携分析
    Summary Fujifilm SonoSite Inc (Fujifilm SonoSite), a subsidiary of Fujifilm Holdings Corp, is a medical device company. It designs and develops ultrasound systems for use in a variety of medical specialties including anesthesiology, cardiology, critical care, endocrinology, orthopedic surgery, radio …
  • Teleplan International NV:企業の戦略的SWOT分析
    Teleplan International NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Komax Holding AG (KOMN):企業の財務・戦略的SWOT分析
    Komax Holding AG (KOMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Daimler AG (DAI)-エネルギー分野:企業M&A・提携分析
    Summary Daimler AG (Daimler) is an automobile company that undertakes the manufacture, distribution and sales of premium passenger cars, commercial vehicles and related spare part and accessories. The company also provides services such as financing, leasing, fleet management, insurance, financial i …
  • United Internet AG:企業のM&A・事業提携・投資動向
    United Internet AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's United Internet AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆